• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

CEO tenure and stock performance





The stock is down 42% since the smiling killer took the helm. Is anyone surprised that our board of directors selected a complete dud? This guy had been on the bench for 8 years after getting canned from his last job as CEO.